查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1628144

電生理學市場機會、成長促進因素、產業趨勢分析與預測 2025 - 2034

Electrophysiology Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 132 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球電生理學市場價值為 69 億美元，預計 2025 年至 2034 年複合年成長率為 10.4%。此領域使用心電圖 (ECG)、肌電圖 (EMG) 和膜片鉗記錄等各種技術來測量和分析電訊號。

心房顫動（AF）等心臟疾病的盛行率不斷上升是市場成長的主要動力。隨著全球人口老化，對電生理學先進診斷和治療方案的需求不斷成長。醫療保健提供者正致力於更好地管理心臟問題，這促進了電生理技術的採用。

技術創新也大大推動了市場擴張。電生理學設備變得越來越先進，提高了治療效果和安全性。微創導管消融手術越來越受歡迎，因為這些技術可以為心律不整和其他心臟病患者提供更好的治療效果。

市場範圍
開始年份 2024年
預測年份 2025-2034
起始值 69 億美元
預測值 188 億美元
複合年成長率 10.4%

市場依產品分為電生理學 (EP) 消融導管、診斷導管和 EP 實驗室設備。 EP 消融導管佔最大佔有率，到 2024 年將佔市場的 49.1%。高解析度測繪系統等現代技術提高了消融的精度，針對異常電訊號，對周圍健康組織的傷害最小。

不同類型的消融導管，例如使用射頻 (RF)、冷凍消融和雷射能量的消融導管，根據特定病例和患者需求為臨床醫生提供了一系列選擇。特別是冷凍消融術可以最大程度地減少熱損傷，使其成為某些手術的首選。現在許多導管都具有即時監控功能，確保消融過程安全有效。

依適應症，市場分為心房顫動、室性心搏過速、心房撲動等病症。心房顫動是最大的細分市場，由於全球範圍內心房顫動發病率的上升，預計未來幾年將顯著成長。

對於最終用戶，電生理學市場服務於醫院、導管實驗室、門診手術中心和其他醫療機構。尤其是醫院在這一領域佔據主導地位，擁有提供先進診斷和治療選擇的專業部門。這些醫院通常擁有專門的電生理學團隊和最先進的設備，以確保高品質的護理。

在完善的醫療保健體系、監管支援和先進的醫療設施的支持下，美國市場預計將大幅成長。該國的基礎設施和 FDA 的新技術核准流程創造了有利於電生理學領域創新的環境，確保了尖端設備和技術的持續開發和採用。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 心房顫動的盛行率不斷增加
      • 電生理設備的技術進步
      • 對電生理導管消融的偏好日益增加
    • 產業陷阱與挑戰
      • 電生理設備投資高
      • 新興國家缺乏熟練的專業人員
  • 成長潛力分析
  • 監管環境
  • 技術景觀
    • 核心技術
    • 鄰近技術
  • 未來市場趨勢
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司市佔率分析
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章：市場估計與預測：按產品分類，2021 - 2034 年

  • 主要趨勢
  • EP消融導管
    • 射頻 (RF)
    • 冷凍消融
    • 雷射
    • 其他 EP 消融導管
  • EP診斷導管
    • 傳統的
    • 先進的
    • 超音波
  • EP實驗室設備
    • 測繪系統
    • 錄音系統
    • 其他EP實驗室設備

第 6 章：市場估計與預測：按指標分類，2021 - 2034 年

  • 主要趨勢
  • 心房震顫
  • 室性心搏過速
  • 房性心搏過速
  • 心房撲動
  • WOLFF-帕金森-懷特 (WPW) 症候群
  • 房室結折返性心搏過速

第 7 章：市場估計與預測：按最終用途，2021 - 2034 年

  • 主要趨勢
  • 醫院
  • 導管插入/電生理實驗室
  • 門診手術中心
  • 其他最終用戶

第 8 章：市場估計與預測：按地區分類，2021 - 2034 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 俄羅斯
    • 烏克蘭
    • 波蘭
    • 瑞士
    • 比利時
    • 希臘
    • 捷克共和國
    • 荷蘭
    • 瑞典
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 馬來西亞
    • 印尼
    • 泰國
    • 新加坡
    • 台灣
    • 菲律賓
    • 越南
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 科威特
    • 阿拉伯聯合大公國

第 9 章：公司簡介

  • Abbott Laboratories
  • APN Health
  • Atricure
  • Biotronik
  • Boston Scientific Corporation
  • CardioFocus
  • GE Healthcare Technologies
  • Japan Lifeline
  • Johnson & Johnson
  • Koninklijke Philips
  • Medtronic
  • Microport Scientific Corporation
  • Merit Medical Systems
  • Siemens Healthineers
  • Stereotaxis
簡介目錄
Product Code: 2968

The Global Electrophysiology Market was valued at USD 6.9 billion in 2024 and is expected to grow at a CAGR of 10.4% from 2025 to 2034. Electrophysiology studies the electrical properties of biological tissues and cells, particularly focusing on nerve and muscle cells. This field uses various techniques such as electrocardiography (ECG), electromyography (EMG), and patch-clamp recordings to measure and analyze electrical signals.

The increasing prevalence of heart conditions like atrial fibrillation (AF) is a major driver of market growth. As the global population ages, the demand for advanced diagnostic and treatment options in electrophysiology is growing. Healthcare providers are focusing on better management of cardiac issues, which is boosting the adoption of electrophysiological techniques.

Technological innovations are also significantly fueling market expansion. Electrophysiology devices are becoming more advanced, improving treatment efficacy and safety. The popularity of catheter ablation procedures, which are minimally invasive, is rising as these techniques offer better outcomes for patients with arrhythmias and other heart conditions.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$6.9 Billion
Forecast Value$18.8 Billion
CAGR10.4%

The market is segmented by product into electrophysiology (EP) ablation catheters, diagnostic catheters, and EP laboratory devices. EP ablation catheters accounted for the largest share, making up 49.1% of the market in 2024. These catheters are designed to deliver energy directly to the tissue causing irregular heartbeats. Modern technologies like high-resolution mapping systems improve the precision of ablation, targeting the abnormal electrical signals with minimal harm to surrounding healthy tissue.

Different types of ablation catheters, such as those using radiofrequency (RF), cryoablation, and laser energy, offer clinicians a range of options depending on the specific case and patient needs. Cryoablation, in particular, minimizes thermal damage, making it a preferred choice in some procedures. Many of these catheters now feature real-time monitoring capabilities, ensuring that the ablation process is both safe and effective.

By indication, the market is divided into atrial fibrillation, ventricular tachycardia, atrial flutter, and other conditions. The atrial fibrillation segment is the largest and is expected to see significant growth in the coming years due to the rising incidence of the condition worldwide.

Regarding end users, the electrophysiology market serves hospitals, catheterization laboratories, ambulatory surgery centers, and other healthcare facilities. Hospitals, in particular, dominate this segment, with specialized departments that offer advanced diagnostics and treatment options. These hospitals often have dedicated electrophysiology teams and state-of-the-art equipment that ensures high-quality care.

The U.S. market is expected to see substantial growth, supported by a well-established healthcare system, regulatory support, and advanced medical facilities. The country's infrastructure and the FDA's approval processes for new technologies create an environment conducive to innovation in the electrophysiology space, ensuring the continued development and adoption of cutting-edge devices and techniques.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of atrial fibrillation
      • 3.2.1.2 Technological advancements in electrophysiology devices
      • 3.2.1.3 Increasing preference for electrophysiology catheter ablation
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High investment for electrophysiology devices
      • 3.2.2.2 Dearth of skilled professionals in emerging nations
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
    • 3.5.1 Core technologies
    • 3.5.2 Adjacent technologies
  • 3.6 Future market trends
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 EP ablation catheters
    • 5.2.1 Radiofrequency (RF)
    • 5.2.2 Cryoablation
    • 5.2.3 Laser
    • 5.2.4 Other EP ablation catheters
  • 5.3 EP diagnostic catheters
    • 5.3.1 Conventional
    • 5.3.2 Advanced
    • 5.3.3 Ultrasound
  • 5.4 EP laboratory devices
    • 5.4.1 Mapping systems
    • 5.4.2 Recording systems
    • 5.4.3 Other EP laboratory devices

Chapter 6 Market Estimates and Forecast, By Indication, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Atrial fibrillation
  • 6.3 Ventricular tachycardia
  • 6.4 Atrial tachycardia
  • 6.5 Atrial flutter
  • 6.6 WOLFF-Parkinson-white (WPW) syndrome
  • 6.7 Atrioventricular nodal reentry tachycardia

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Catheterization/EP laboratories
  • 7.4 Ambulatory surgery centers
  • 7.5 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Russia
    • 8.3.7 Ukraine
    • 8.3.8 Poland
    • 8.3.9 Switzerland
    • 8.3.10 Belgium
    • 8.3.11 Greece
    • 8.3.12 Czech Republic
    • 8.3.13 Netherlands
    • 8.3.14 Sweden
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Malaysia
    • 8.4.7 Indonesia
    • 8.4.8 Thailand
    • 8.4.9 Singapore
    • 8.4.10 Taiwan
    • 8.4.11 Philippines
    • 8.4.12 Vietnam
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 Kuwait
    • 8.6.4 UAE

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
  • 9.2 APN Health
  • 9.3 Atricure
  • 9.4 Biotronik
  • 9.5 Boston Scientific Corporation
  • 9.6 CardioFocus
  • 9.7 GE Healthcare Technologies
  • 9.8 Japan Lifeline
  • 9.9 Johnson & Johnson
  • 9.10 Koninklijke Philips
  • 9.11 Medtronic
  • 9.12 Microport Scientific Corporation
  • 9.13 Merit Medical Systems
  • 9.14 Siemens Healthineers
  • 9.15 Stereotaxis